1-2 of 2
Michelle Amundson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

LS1781 (Arm E): Phase II clinical trial to assess the safety and efficacy of high dose IV ascorbic acid with decitabine in newly diagnosed TET2 mutant chronic myelomonocytic leukemia (CMML)

Free
Abhishek Mangaonkar, Jenna Fernandez, Ashya Burgess, Kristen McCullough, Christy Finke, Terra Lasho, Michelle Amundson, Antoine Saliba, Aasiya Matin, Aref Al-Kali, Hassan Alkhateeb, Mithun Shah, Betsy Knopf, Thomas Witzig, Mrinal Patnaik
Journal: Blood
Blood (2025) 146 (Supplement 1): 2079.
https://doi.org/10.1182/blood-2025-2079
Published: 2025
Journal Articles

High-dose IV ascorbic acid therapy for patients with CCUS with TET2 mutations

Free
Zhuoer Xie, Jenna Fernandez, Terra Lasho, Christy Finke, Michelle Amundson, Kristen B. McCullough, Betsy R. LaPlant, Abhishek A. Mangaonkar, Naseema Gangat, Kaaren K. Reichard, Michelle Elliott, Thomas E. Witzig, Mrinal M. Patnaik
Journal: Blood
Blood (2024) 144 (23): 2456–2461.
https://doi.org/10.1182/blood.2024024962
Published: 2024
Includes: Supplemental data